—
Total Companies
—
Total Disclosed Funding
—
Clinical Stage
—
Acquired / M&A
By Modality
By Development Stage
By Funding Stage
By Region
By Isotope
By Molecular Target
M&A Deal Flow & Strategic Partnerships
Major transactions shaping the radiopharmaceutical landscape
Competitive Landscape
Target × Isotope matrix — identifying white space and crowded positions
| Company | Region | Modality | Dev. Stage | Isotope(s) | Target(s) | MOA | Funding | Total Raised ($M) | Pipeline | Notes |
|---|